{"id":3441,"date":"2026-01-15T14:54:16","date_gmt":"2026-01-15T13:54:16","guid":{"rendered":"https:\/\/www.amsvita.com\/en\/?p=3441"},"modified":"2026-03-28T14:56:09","modified_gmt":"2026-03-28T13:56:09","slug":"biological-safety-in-autologous-regenerative-medicine","status":"publish","type":"post","link":"https:\/\/www.amsvita.com\/en\/news\/biological-safety-in-autologous-regenerative-medicine\/","title":{"rendered":"Biological Safety in Autologous Regenerative Medicine"},"content":{"rendered":"\n

Autologous approach and immunological safety<\/strong><\/h2>\n\n\n\n

Autologous regenerative medicine based on adipose tissue relies on the use of the patient\u2019s own stromal vascular fraction<\/strong> (SVF) and adipose-derived mesenchymal stem cells (ASCs), which are naturally present within adipose tissue. These cells are multipotent and can differentiate toward several mesenchymal lineages, including osteogenic, chondrogenic, myogenic, hepatogenic, and endothelial phenotypes, supporting their role in tissue repair and regeneration. The autologous nature of these preparations is central to their biological safety profile, as it avoids exposure to allogeneic antigens and the associated risk of classical immune rejection. Clinical applications have been reported in degenerative musculoskeletal conditions and aesthetic rejuvenation, where autologous adipose tissue grafts provide both volumizing and regenerative effects.<\/p>\n\n\n\n

Mesenchymal stem cells derived from adipose tissue exhibit immunomodulatory<\/strong> and antifibrotic properties, in addition to their differentiation capacity. These characteristics are considered relevant to the observed clinical effects of adipose tissue grafting, such as improved skin trophism, accelerated closure of complex wounds or ulcers, and enhancement of skin appearance after radiotherapy damage. In the context of osteoarthritis, autologous regenerative therapy (ART) using adipose-derived SVF has been described as an innovative approach that exploits the ability of mesenchymal cells to respond to local signals and growth factors within the joint environment, thereby supporting cartilage and soft tissue repair.<\/p>\n\n\n\n

The use of autologous adipose-derived SVF and ASCs has been associated with a favorable safety profile in clinical series. In a cohort of patients with hip and knee osteoarthritis treated with intra-articular injection of autologous fat micrograft obtained with a SEFFICARE-based technique, the injected material was reported to be well tolerated, with no adverse events or infections at the joint level and only transient swelling and low-grade pain for a few days. The authors explicitly attribute this tolerability to the autologous origin of the injected tissue. Similarly, the donor site course was uneventful apart from minimal discomfort, edema, and ecchymosis, and no major complications were observed.<\/p>\n\n\n\n

Beyond individual clinical series, the broader literature cited within these works indicates that autologous adipose tissue contains several types of multipotent cells and can be used as a source of multipotent stem cells<\/strong> for cell-based therapies. Clinical studies have demonstrated the efficacy of autologous mesenchymal stem cell grafting in accelerating healing and regenerative processes of skin and mesenchymal tissues, reinforcing the concept that autologous approaches can combine regenerative efficacy with a reassuring safety profile. The absence of reported immune-mediated complications in these autologous applications supports their immunological safety in appropriately selected indications and protocols.<\/p>\n\n\n\n

Reduction of contamination and rejection risk<\/strong><\/h2>\n\n\n\n

The risk of contamination and rejection in autologous regenerative medicine is influenced by both the biological nature of the graft and the technical aspects of harvesting and processing. Autologous adipose tissue grafts inherently avoid the introduction of foreign antigens, thereby minimizing the risk of classical immunological rejection. In the osteoarthritis series using intra-articular autologous fat micrograft, the injected joints did not show infections or adverse events, and the material was described as well tolerated, which is consistent with the expectation of low immunogenicity for autologous tissue. The donor sites similarly showed no infections, with only minor, self-limited local effects such as edema and ecchymosis.<\/p>\n\n\n\n

Technical strategies to reduce contamination risk are evident in the described SEFFICARE-guided procedures. Every procedure in the osteoarthritis cohort was performed under complete aseptic technique<\/strong> and with antibiotic prophylaxis for five days after treatment. The device is an all-in-one, disposable system that includes the harvesting cannula and guide, designed to standardize the procedure and limit environmental exposure of the tissue. The adipose tissue is aspirated manually with a syringe\u2013cannula\u2013guide system, transferred into syringes for washing and decantation, and then injected, all within a closed, syringe-based workflow that minimizes handling steps and contact with ambient air.<\/p>\n\n\n\n

The harvesting technique itself is designed to limit mechanical trauma and unnecessary manipulation, which can preserve cell viability and reduce the need for additional processing steps that might introduce contamination. Tissue is harvested with minimal pressure using a syringe rather than an aspiration device, and washing is performed by decantation instead of centrifugation. A study cited in this context demonstrated that adipose tissue harvested with minimal pressure, washed by decantation, subjected to minimal manipulation, and minimally exposed to ambient air resulted in a higher rate of viable cells compared with techniques involving more intensive mechanical manipulation. By reducing the number of open manipulations and devices, these protocols may also reduce the opportunities for microbial contamination.<\/p>\n\n\n\n

In comparative analyses of harvesting and processing techniques, adipose tissue obtained with guided microcannulas featuring small side-port holes (0.8 and 1 mm) and without chemical or mechanical manipulation was shown to contain viable and proliferative cells, with cell viability comparable to tissue processed by standard liposuction followed by enzymatic digestion. The conclusion of this study emphasizes that minimally invasive harvesting and minimal manipulation can yield tissue with a good amount of viable cells and that such micro-fragmented adipose tissue is a promising source for regenerative treatments. By avoiding enzymatic digestion and complex processing, these approaches may reduce both contamination risk and procedural variability while maintaining biological quality.<\/p>\n\n\n\n

Sterility and cell integrity standards<\/strong><\/h2>\n\n\n\n

Sterility and preservation of cell integrity<\/strong> are central to the biological safety of autologous regenerative procedures. In the SEFFICARE-based osteoarthritis protocol, the entire procedure\u2014from harvesting to injection\u2014is conducted under complete aseptic technique, and patients receive a short course of antibiotic prophylaxis after treatment. The device is CE-marked as a class IIA medical device and is supplied as an all-in-one, disposable kit containing all materials required for harvesting, washing, and injection. This configuration supports standardized handling and reduces the need for external instruments, which can help maintain sterility throughout the workflow.<\/p>\n\n\n\n

The SEFFI technique is explicitly designed to generate a highly fluid preparation of adipose tissue clusters during the harvesting step, without the need for further manipulation. The adipose tissue is dissociated into small clusters by a cannula with small side-port holes, and the harvested tissue is washed by decantation in saline solution before injection. This approach avoids centrifugation and other mechanical processing steps that could compromise cell membranes or alter the extracellular matrix. A referenced study demonstrated that tissue harvested with this minimal-manipulation technique showed higher viability and growth rate compared with techniques involving mechanical manipulation of the harvested tissue.<\/p>\n\n\n\n

Independent evaluations of adipose tissue harvested with small-port microcannulas further support the preservation of cell viability. In a study comparing adipose tissue harvested with 0.8 mm and 1 mm side-port cannulas to tissue obtained by standard liposuction followed by enzymatic digestion, all samples were vital and contained metabolically active cells, as demonstrated by increased absorbance in a resazurin-based viability assay over 72 hours. The two microcannula systems yielded similar absorbance values at baseline and after incubation, indicating equivalent viability, and values at 72 hours were similar to those of SVF cells derived by enzymatic digestion. These findings confirm that guided harvesting with small cannulas does not adversely affect cell viability and can provide tissue suitable for regenerative applications.<\/p>\n\n\n\n

Characterization studies of micro-SEFFI tissue used for facial aging treatment have shown that adipose tissue harvested with SEFFI and micro-SEFFI systems yields samples with high fluidity and defined cellular composition, including stromal vascular fraction cells from which ASCs can be isolated. Despite the small cluster size and relatively low cellularity of micro-SEFFI-derived tissue, stem cells with good proliferation rate and differentiation potential toward mesenchymal lineages were successfully isolated. These data indicate that harvesting protocols designed to minimize manipulation and maintain sterility can still preserve the functional integrity of stromal cells, which is essential for the regenerative potential and safety of autologous grafts.<\/p>\n\n\n\n

Minimal manipulation principles<\/strong><\/h2>\n\n\n\n

The concept of minimal manipulation<\/strong> is a defining feature of several autologous adipose-based regenerative protocols described in the available evidence. In the SEFFI and SEFFICARE systems, the rationale is to obtain a highly fluid adipose tissue preparation directly during harvesting, thereby avoiding subsequent processing steps that could alter the structural and cellular characteristics of the tissue. The cannulas used have small side-port holes that mechanically fragment the adipose tissue into microclusters during aspiration, and the tissue is then simply washed by decantation in saline solution before injection. No centrifugation, filtration, or enzymatic digestion is required, and the tissue is not subjected to substantial mechanical manipulation beyond the initial aspiration and gentle syringe transfers.<\/p>\n\n\n\n

Experimental data support the biological rationale for limiting manipulation. A comparative study of harvesting and processing techniques demonstrated that adipose tissue harvested with guided microcannulas (0.8 and 1 mm side-port holes) without chemical or mechanical manipulation contained viable and proliferative cells, with cell viability comparable to that of tissue processed by standard liposuction followed by collagenase digestion. The increase in metabolic activity over 72 hours indicated that both the tissue and the cells released by the mechanical action of the cannula remained vital. The authors concluded that minimally invasive harvesting and minimal manipulation yield tissue with a good amount of viable cells and that such micro-fragmented adipose tissue is a promising source for regenerative therapy.<\/p>\n\n\n\n

The SEFFI technique explicitly emphasizes that any mechanical tissue manipulation leads to a reduction in stemness and cell viability, and cites evidence that tissue harvested with this technique, without substantial manipulation, has higher viability and growth rate than tissue processed with additional mechanical steps. By integrating fragmentation into the harvesting phase and using decantation for washing, the protocol adheres to minimal manipulation principles while still producing a preparation that is sufficiently fluid for injection through small-gauge needles or cannulas. This approach aligns with the broader objective of preserving the native microenvironment of stromal cells within adipose clusters, which may be important for their regenerative behavior.<\/p>\n\n\n\n

In facial rejuvenation, micro-SEFFI represents an evolution of these principles, using cannulas with even smaller side-port holes (0.3 mm) to obtain highly fluid micrografts suitable for superficial injections in areas with thin skin. The technique requires minimal manipulation and does not require additional devices for graft processing, relying instead on the intrinsic properties of the harvested microfat. Characterization studies have confirmed that, despite the small size of the adipose clusters and lower overall cellularity, it is still possible to isolate ASCs with robust proliferation and differentiation capacity from micro-SEFFI-derived tissue. These findings support the feasibility of combining minimal manipulation with clinically useful regenerative potential in autologous adipose-based therapies.<\/p>\n\n\n\n

Clinical safety outcomes<\/strong><\/h2>\n\n\n\n

Clinical safety outcomes of autologous adipose-based regenerative procedures have been reported in both musculoskeletal and aesthetic contexts. In a retrospective series of 250 patients with hip and knee osteoarthritis treated with intra-articular injection of autologous fat micrograft using the SEFFICARE device, the donor site postoperative course was described as uneventful apart from minimal discomfort, edema, and ecchymosis, with no adverse events such as pain or infection and no major complications. At the injected joint, postoperative findings were limited to swelling and low-grade pain for 3\u20137 days, with no adverse events or infections observed. These observations indicate a low incidence of acute complications in this cohort.<\/p>\n\n\n\n

In terms of functional and symptomatic outcomes, the same osteoarthritis cohort showed improvements in range of motion (ROM), stiffness, and pain over follow-up. Clinical results in terms of increased ROM and reduced stiffness appeared around three months after treatment, while reductions in pain, as measured by a visual analogue scale (VAS), began at three months and reached a peak at six months for the knee and between six and twelve months for the hip. Table-based analyses indicated that patients with lower radiographic grades of osteoarthritis (Kellgren\u2013Lawrence grade 1\u20132 and T\u00f6nnis grade 1\u20132) experienced improvements in ROM and reductions in VAS scores over time. Although the study has limitations, including its retrospective design and absence of a control group, the reported data support the feasibility and safety of the procedure in this setting.<\/p>\n\n\n\n

Patient-reported outcomes further complement the safety profile. In the osteoarthritis series, the SF-12 questionnaire was completed by a majority of patients, with mean physical and mental component scores in ranges consistent with preserved functional status and quality of life. At one year, 85% of patients reported being completely satisfied with the treatment and willing to undergo it again, citing considerable improvements in pain and quality of life. Over a five-year follow-up, only a small proportion of patients proceeded to joint replacement surgery, and these were predominantly older individuals with more advanced disease. While these observations do not replace controlled comparative data, they provide additional reassurance regarding the tolerability of the autologous procedure.<\/p>\n\n\n\n

Beyond this single-center experience, the cited literature includes a systematic review on the safety of intra-articular cell therapy with culture-expanded stem cells in humans, which is referenced in the osteoarthritis article as supporting the safety of such approaches. The osteoarthritis study concludes that the use of autologous adipose-derived SVF for osteoarthritis treatment was safe and feasible, in line with previous reports. In aesthetic and reconstructive applications, clinical studies have also demonstrated the efficacy of autologous mesenchymal stem cell grafting in accelerating healing and regeneration of skin and mesenchymal tissues, with adipose tissue grafting used to improve skin trophism, wound closure, and skin appearance after radiotherapy, again without highlighting major safety concerns. Collectively, these data support a favorable clinical safety profile for autologous adipose-based regenerative procedures when performed with standardized, minimally manipulative techniques.<\/p>\n\n\n\n

Regulatory framework and guidelines<\/strong><\/h2>\n\n\n\n

The regulatory landscape for autologous regenerative medicine is closely linked to the degree of tissue manipulation and the methods used for cell isolation. In the comparative study of adipose tissue harvesting and processing, enzymatic digestion with collagenase is described as the gold-standard method for isolating SVF cells, as it disrupts the extracellular matrix and releases adipocytes and other stromal cells. However, the same study notes that enzymatic procedures are subject to regulatory restrictions, particularly within the European Community. These constraints have stimulated interest in non-enzymatic, minimally manipulative techniques that can provide viable, regenerative tissue while remaining within less stringent regulatory categories.<\/p>\n\n\n\n

The SEFFI and SEFFICARE systems exemplify this trend toward mechanically based, minimal manipulation protocols. The SEFFICARE device is described as a CE-marked class IIA medical device, all-in-one and disposable, designed to perform autologous regenerative treatments in a safe, standardized, and effective way. The device includes a guide that standardizes cannula depth at 15 mm to target the superficial adipose tissue layer, which is reported to contain higher concentrations of mesenchymal and vascular stem cells. By avoiding enzymatic digestion and limiting processing to mechanical fragmentation and saline decantation, these systems align with regulatory expectations for minimal manipulation of autologous tissue.<\/p>\n\n\n\n

The emphasis on minimal manipulation is not only a biological consideration but also a regulatory one. The SEFFI technique is explicitly based on the rationale that a highly fluid adipose tissue preparation can be generated during harvesting without further manipulation, and it is noted that additional mechanical manipulation reduces stemness and cell viability. The supporting cell viability study concludes that adipose tissue harvested with guided microcannulas and without substantial manipulation presents viable and proliferative cells and is a promising tissue for regenerative therapy. These findings support the feasibility of developing autologous regenerative products that remain within regulatory definitions of minimally manipulated tissue while still providing biologically active grafts.<\/p>\n\n\n\n

Intellectual property and device development also intersect with the regulatory framework. The guide component of the SEFFICARE device is reported to be patented in Italy, and related technologies for stem cell fractionation and microfluidic sorting are described in patents cited within the characterization studies of micro-SEFFI tissue. These developments reflect ongoing efforts to standardize harvesting and processing methods in ways that are compatible with existing regulations while enabling reproducible, quality-controlled autologous regenerative treatments. Within this context, adherence to aseptic technique, use of certified medical devices, and strict limitation of tissue manipulation are key elements of the practical regulatory framework governing biological safety in autologous regenerative medicine.<\/p>\n\n\n\n

Sources (Bibliography)<\/strong><\/h2>\n\n\n\n
    \n
  • Trentani P, Meredi E, Zarantonello P, Gennai A. Role of autologous micro-fragmented adipose tissue in osteoarthritis treatment. J Pers Med, 2024.<\/li>\n\n\n\n
  • Gennai A, Bovani B, Colli M, et al. Comparison of harvesting and processing technique for adipose tissue graft: evaluation of cell viability. Int J Regener Med, 2021.<\/li>\n\n\n\n
  • Rossi M, Roda B, Zia S, et al. Characterization of the tissue and stromal cell components of micro-superficial enhanced fluid fat injection (micro-SEFFI) for facial aging treatment. Aesthetic Surg J, 2019.<\/li>\n\n\n\n
  • Gennai A. Comparison of harvesting and processing technique for adipose tissue graft: evaluation of cell viability. Supplementary related content, 2021.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"

    Autologous approach and immunological safety Autologous regenerative medicine based on adipose tissue relies on the use of the patient\u2019s own stromal vascular fraction (SVF) and adipose-derived mesenchymal stem cells (ASCs), which are naturally present within adipose tissue. These cells are multipotent and can differentiate toward several mesenchymal lineages, including osteogenic, chondrogenic, myogenic, hepatogenic, and endothelial […]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[59,8],"tags":[57,58],"_links":{"self":[{"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/posts\/3441"}],"collection":[{"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/comments?post=3441"}],"version-history":[{"count":1,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/posts\/3441\/revisions"}],"predecessor-version":[{"id":3442,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/posts\/3441\/revisions\/3442"}],"wp:attachment":[{"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/media?parent=3441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/categories?post=3441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.amsvita.com\/en\/wp-json\/wp\/v2\/tags?post=3441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}